1. Home
  2. STHO vs VERU Comparison

STHO vs VERU Comparison

Compare STHO & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STHO

Star Holdings Shares of Beneficial Interest

HOLD

Current Price

$7.62

Market Cap

112.7M

Sector

Real Estate

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.47

Market Cap

39.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STHO
VERU
Founded
N/A
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.7M
39.8M
IPO Year
N/A
1990

Fundamental Metrics

Financial Performance
Metric
STHO
VERU
Price
$7.62
$2.47
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$25.00
AVG Volume (30 Days)
47.9K
108.8K
Earning Date
11-07-2025
12-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$117,547,000.00
$16,886,419.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
337.24
52 Week Low
$6.06
$2.11
52 Week High
$10.63
$14.20

Technical Indicators

Market Signals
Indicator
STHO
VERU
Relative Strength Index (RSI) 49.82 40.04
Support Level $7.56 $2.33
Resistance Level $7.77 $2.70
Average True Range (ATR) 0.20 0.15
MACD -0.01 0.05
Stochastic Oscillator 25.42 42.86

Price Performance

Historical Comparison
STHO
VERU

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: